Total effectiveness rate with subgroup analysis ‐ individualised treatment Clinician's rating · atopic eczema
CHM may leads to higher total effectiveness rate with subgroup analysis ‐ individualised… compared with drugs (low certainty).
1 finding from 1 review
Total effectiveness rate with subgroup analysis ‐ non‐individualised treatment Clinician's rating · atopic eczema
It is very uncertain whether CHM changes total effectiveness rate with subgroup analysis ‐ non‐individualised… compared with drugs (very low certainty).
1 finding from 1 review
Cognitive function · People with vascular dementia
1 finding from 1 review
Cognition‐ADAS‐Cog ‐ not measured · People with vascular dementia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global performance (improved) ‐ not measured · People with vascular dementia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (AEs) (1 or more events) · People with vascular dementia
FuFangHaiShe showed no clear difference in adverse events (AEs) (1 or more) compared with 'no treatment' (low certainty).
1 finding from 1 review
Activities of daily living · People with vascular dementia
1 finding from 1 review
Behaviour ‐ not measured · People with vascular dementia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive function · People with vascular dementia
2 findings from 1 review
Cognition‐ADAS‐Cog ‐ not measured · People with vascular dementia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global performance (improved) ‐ only measured in one study · People with vascular dementia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (AEs) (1 or more events) · People with vascular dementia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognition‐HDS ‐ not measured · People with vascular dementia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Activities of daily living · People with vascular dementia
1 finding from 1 review
Behaviour ‐ not measured · People with vascular dementia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive function · People with vascular dementia
2 findings from 1 review
Cognition‐ADAS‐Cog ‐ not measured · People with vascular dementia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global performance (improved) ‐ not measured · People with vascular dementia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (AEs) (1 or more events) · People with vascular dementia
YinDanXingNaoTong showed no clear difference in adverse events (AEs) (1 or more events) compared with 'no treatment' (low certainty).
1 finding from 1 review
Activities of daily living · People with vascular dementia
1 finding from 1 review